BILL NUMBER: SB 587	AMENDED
	BILL TEXT

	AMENDED IN SENATE  JANUARY 4, 2016
	AMENDED IN SENATE  APRIL 9, 2015

INTRODUCED BY   Senator Stone

                        FEBRUARY 26, 2015

   An act to  amend Section 4052.2   add Section
18645.5  of the Business and Professions Code, relating to
 pharmacy.   the State Athletic Commission.



	LEGISLATIVE COUNSEL'S DIGEST


   SB 587, as amended, Stone.  Pharmacy: drug regimens:
hypertension and hyperlipidemia.   The State Athletic
Commission.  
   Under existing law, the State Athletic Commission Act, the State
Athletic Commission has jurisdiction over all professional and
amateur boxing, professional and amateur kickboxing, all forms and
combinations of forms of full contact martial arts contests,
including mixed martial arts, and matches or exhibitions conducted,
held, or given within this state.  
   This bill would require the State Athletic Commission to establish
a task force to evaluate the impacts of weight cutting, dehydration,
and rapid rehydration, as prescribed.  
   Existing law, the Pharmacy Law, provides for the licensure and
regulation of pharmacists and pharmacy corporations in this state by
the California State Board of Pharmacy. That law authorizes a
pharmacist to perform listed procedures or functions as part of the
care provided by specified health care entities, including initiating
or adjusting the drug regimen of a patient pursuant to a specific
written order or authorization made by the individual patient's
treating prescriber, and in accordance with the policies, procedures,
or protocols of the health care entity.  
   This bill would specifically include the treatment of hypertension
and hyperlipidemia in the authorized initiation or adjustment of a
patient's drug regimen. 
   Vote: majority. Appropriation: no. Fiscal committee:  no
  yes  . State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

   SECTION 1.    Section 18645.5 is added to the 
 Business and Professions Code   , to read:  
   18645.5.  The commission shall establish a task force to evaluate
the impacts of weight cutting, dehydration, and rapid rehydration.
The task force may be comprised of physicians and surgeons with
expertise in dehydration and rapid rehydration and boxing and mixed
martial arts stakeholders, including licensees. The task force, in
evaluating impacts, shall consider dangers of certain practices
athletes undergo to meet the requirements outlined in Section 18706
and may provide recommendations to the commission that include, but
are not limited to, proper techniques to detect dehydration, outreach
the commission can undertake to educate licensees about dehydration
and rapid rehydration, and the appropriateness of commission weight
classifications established in Section 298 of Article 6 of Chapter 1
of Division 2 of Title 4 of the California Code of Regulations. 

  SECTION 1.    Section 4052.2 of the Business and
Professions Code is amended to read:
   4052.2.  (a) Notwithstanding any other law, a pharmacist may
perform the following procedures or functions as part of the care
provided by a health care facility, a licensed home health agency, a
licensed clinic in which there is a physician oversight, a provider
who contracts with a licensed health care service plan with regard to
the care or services provided to the enrollees of that health care
service plan, or a physician, in accordance with the policies,
procedures, or protocols of that facility, home health agency,
licensed clinic, health care service plan, or physician, and in
accordance with subdivision (c):
   (1) Ordering or performing routine drug therapy-related patient
assessment procedures including temperature, pulse, and respiration.
   (2) Ordering drug therapy-related laboratory tests.
   (3) Administering drugs and biologicals by injection pursuant to a
prescriber's order.
   (4) Initiating or adjusting the drug regimen of a patient pursuant
to a specific written order or authorization made by the individual
patient's treating prescriber, and in accordance with the policies,
procedures, or protocols of the health care facility, home health
agency, licensed clinic, health care service plan, or physician.
Adjusting the drug regimen does not include substituting or selecting
a different drug, except as authorized by the protocol. The
pharmacist shall provide written notification to the patient's
treating prescriber, or enter the appropriate information in an
electronic patient record system shared by the prescriber, of any
drug regimen initiated pursuant to this paragraph within 24 hours.
This function may include, but is not limited to, treatment of
hypertension and hyperlipidemia.
   (b) A patient's treating prescriber may prohibit, by written
instruction, any adjustment or change in the patient's drug regimen
by the pharmacist.
   (c) The policies, procedures, or protocols referred to in this
subdivision shall be developed by health care professionals,
including physicians, pharmacists, and registered nurses, and, at a
minimum, shall do all of the following:
   (1) Require that the pharmacist function as part of a
multidisciplinary group that includes physicians and direct care
registered nurses. The multidisciplinary group shall determine the
appropriate participation of the pharmacist and the direct care
registered nurse.
   (2) Require that the medical records of the patient be available
to both the patient's treating prescriber and the pharmacist.
   (3) Require that the procedures to be performed by the pharmacist
relate to a condition for which the patient has first been seen by a
physician.
   (4) Except for procedures or functions provided by a health care
facility, a licensed clinic in which there is physician oversight, or
a provider who contracts with a licensed health care plan with
regard to the care or services provided to the enrollees of that
health care service plan, require the procedures to be performed in
accordance with a written, patient-specific protocol approved by the
treating or supervising physician. Any change, adjustment, or
modification of an approved preexisting treatment or drug therapy
shall be provided in writing to the treating or supervising physician
within 24 hours.
   (d) Prior to performing any procedure authorized by this section,
a pharmacist shall have done either of the following:
   (1) Successfully completed clinical residency training.
   (2) Demonstrated clinical experience in direct patient care
delivery.